Targeting MEK in vemurafenib-resistant hairy cell leukemia. (2019)
Attributed to:
Wellcome Trust MRC Cambridge Stem Cell Institute
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41375-018-0270-2
PubMed Identifier: 30341394
Publication URI: http://europepmc.org/abstract/MED/30341394
Type: Journal Article/Review
Volume: 33
Parent Publication: Leukemia
Issue: 2
ISSN: 0887-6924